The American Civil Liberties Union and the Public Patent Foundation are seeking a ruling from the US Supreme Court on the validity of gene patents, according to an ACLU statement. The plaintiffs are asking for redress from the high court in their case against Myriad Genetics' patents on the BRCA1 and BRCA2 genes, after a federal appeals court ruled in August that those patents were valid. According to our sister publication Pharmacogenomics Reporter, the Supreme Court could either choose to hear the case, or it could ask the Court of Appeals to reconsider its decision. A Myriad spokeswoman tells PGx Reporter the company is still considering its options, and that it has until December 15 to decide on its next steps.
Gene Patent Case Presses On
Oct 13, 2011